Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan.
Frequently asked questions
What sector does Shine-On BioMedical Co.,Ltd. (6926) operate in?
Shine-On BioMedical Co.,Ltd. belongs to the Other sector and operates in the Biotechnology industry.
What is Shine-On BioMedical Co.,Ltd. (6926) current stock price?
As of the latest data, Shine-On BioMedical Co.,Ltd. stock price is NT$62.80, with a previous close of NT$62.80.
What is Shine-On BioMedical Co.,Ltd. (6926) current market capitalization?
Shine-On BioMedical Co.,Ltd. market cap is approximately 3.13 billion.
What is Shine-On BioMedical Co.,Ltd. (6926) Earnings Per Share (EPS)?
The trailing EPS is -NT$2.21.
Does Shine-On BioMedical Co.,Ltd. (6926) pay dividends?
No. Shine-On BioMedical Co.,Ltd. does not pay a dividend.
What is Shine-On BioMedical Co.,Ltd. (6926) beta (volatility) score?
Shine-On BioMedical Co.,Ltd. has a beta of -0.140, indicating lower volatility than the overall market.